• Client Login
Ozmosi
  • Services
    • BEAM Clinical Trial Data
    • GCT Global Clinical Trials
    • PRYZM Pharma Product Database
    • KRYSTL Industry Scan Reporting
    • LENZ Company Pipeline Summary
    • Specialized Consulting
    • Approved Pharmaceutical Products in Use
  • About Us
  • Case Studies
  • Newsroom
  • Contact Us
Select Page
Who is Winning in Innovation and How are They Balancing Risk?

Who is Winning in Innovation and How are They Balancing Risk?

Oct 28, 2025 | Data Analytics, Industry Trends, Market Scan, New Technology

Examining the innovation-to-risk balance among the pharmaceutical industry’s top companies In our previous post, we evaluated the pharmaceutical industry’s leading companies in terms of overall R&D pipeline strength, resulting in Roche, AstraZeneca, Bristol-Myers...
Who’s Winning the Pharmaceutical R&D Pipeline Race in 2025

Who’s Winning the Pharmaceutical R&D Pipeline Race in 2025

Oct 26, 2025 | Business, Data Analytics, Industry Trends, Market Scan, New Technology, Probability of Success

The leaders, the contenders, and the strategies for success As we approach the 4th quarter of 2025, let’s review where the pharmaceutical industry’s leading companies rank in terms of overall pipeline strength. Roche, AstraZeneca, and Bristol-Myers Squibb sit in a...
Merck Diabetes Pipeline Analysis

Merck Diabetes Pipeline Analysis

Jan 27, 2024 | Business, Data Analytics, Diabetes, Disease Area Trends

Merck’s two blockbuster diabetes products, Janumet® and Januvia®, are DPP-4 inhibitors that generated nearly $3.3 billion in Sales in 2016.3 Januvia® is especially known for its great cardiovascular safety profile, which has helped differentiate itself in its class....

Recent Posts

  • Who is Winning in Innovation and How are They Balancing Risk?October 28, 2025
  • Who’s Winning the Pharmaceutical R&D Pipeline Race in 2025October 26, 2025
  • 7 Small-Cap Biotech Companies to Watch at AACR in AprilOctober 23, 2025
  • How Next-Generation Probability of Success Forecasting Can Improve Clinical Trial Accuracy by 44%October 16, 2025
  • Market Overview: GLP-1 Agonists and the Obesity MarketOctober 16, 2025
  • Not Your Grandparents’ Probability of Success ForecastsOctober 9, 2025
  • Home
  • About Us
  • Services
  • Case Studies
  • Newsroom
  • Contact Us
  • Facebook
  • X
OZMOSI© 2025 | All Rights Reserved | Site by Webtyde